Cholinergic agents elicit prominent smooth muscle contractions via stimulation of muscarinic receptors that comprise five distinct subtypes (M 1 -M 5 ). Although such contractions are important for autonomic organs, the role of each subtype has not been characterized precisely because of the poor selectivity of the currently available muscarinic ligands. Here, we generated a mutant mouse line (M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice) lacking M 2 and M 3 receptors that are implicated in such cholinergic contractions. The relative contributions of M 2 and M 3 receptors in vitro was ϳ5 and 95% for the detrusor muscle contraction and ϳ25 and 75% for the ileal longitudinal muscle contraction, respectively. Thus, M 1 , M 4 , or M 5 receptors do not seem to play a role in such contractions. Despite the complete lack of cholinergic contractions in vitro, M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice were viable, fertile, and free of apparent intestinal complications. The urinary bladder was distended only in males, which excludes a major contribution by cholinergic mechanisms to the urination in females. Thus, cholinergic mechanisms are dispensable in gastrointestinal motility and female urination. After 10 Hz electrical field stimulation, noncholinergic inputs were found to be increased in the ileum of M 2 Ϫ/ϪM 3 Ϫ/Ϫ females, which may account for the lack of apparent functional deficits. Interestingly, the M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice had smaller ocular pupils than M 3 -deficient mice. The results suggest a novel role of M 2 in the pupillary dilation, contrary to the well known cholinergic constriction. These results collectively suggest that an additional mechanism operates in the control of pupillary constriction-dilatation.
Acetylcholine (ACh) is the most common neurotransmitter at the parasympathetic nerve ending to induce smooth muscle contractions. In the gastrointestinal tract, ACh is released from the primary excitatory motor neurons and mediates an immediate smooth muscle contraction (Goyal and Hirano, 1996; Furness, 2000) . Activities of the motor neurons in the gut wall are coordinated by the enteric nervous system to generate functional movement, such as peristalsis. Although the excitatory enteric neurons corelease other transmitters, such as tachykinins (Holzer and Holzer-Petsche, 1997) , ACh is believed to be functionally predominant in inducing contractions (Goyal and Hirano, 1996; Furness, 2000) .
The cholinergic signaling is mediated by the muscarinic ACh receptor expressed on the surface of the smooth muscle cells. To date, five subtypes (M 1 -M 5 ) of muscarinic receptors have been identified, which are variable in both the tissue distribution and signal transduction mechanisms (Caulfield and Birdsall, 1998) . Delineating the role of these receptors has been a matter of considerable interest, because they are promising therapeutic targets for various diseases ). However, their pharmacological characterization remains inconclusive because of the poor subtype selectivity of available ligands. In the intestine, for example, M 3 is considered to be predominant in eliciting cholinergic contraction, whereas the role of the more abundant M 2 remains unclear (Ehlert et al., 1999; Eglen, 2001) .
To overcome such technical problems, mutant mice deficient in each individual subtype have been constructed (Hamilton et al., 1997; Gomeza et al., 1999a,b; Matsui et al., 2000; Yamada et al., 2001a,b) . Notably, all five mutant mouse lines are viable, which suggests a functional redundancy among the subtypes. The mice deficient in either M 2 or M 3 receptors show decreased responses to cholinergic stimuli (Matsui et al., 2000; Stengel et al., 2000) , but precise mechanisms of the residual contractions remain to be elucidated.
Here, we generated mutant mice lacking both M 2 and M 3 receptors and studied the role of these subtypes in various smooth muscle organs. In addition, we used electrical field stimulation (EFS) and evaluated the in vivo significance of cholinergic smooth muscle contraction.
MATERIALS AND METHODS

Construction of a targeting vector for disruption of M 2 receptor gene.
A targeting vector, pChrm2-N1 (Fig. 1 A) , was constructed using the mouse M 2 genomic fragments (Matsui et al., 1999) . The BamHI-EcoRI (1.0 kb) and SmaI-BamHI (8.5 kb) fragments were placed upstream and downstream of the PGK-neo-bpA cassette (Soriano et al., 1991) , respectively. The PGK-DTA cassette (Yagi et al., 1990 ) was inserted at the upstream end in reverse orientation.
Gene targeting in embr yonic stem cells. The gene targeting in embryonic stem cells (RW4; Genome Systems, St. L ouis, MO) was performed as described previously (Matsui et al., 2000) . G418-resistant cells were screened by PCR using primers M F13 (5Ј-CCC TGC TTC AAA TAC TTG TCC -3Ј) and PR1 (5Ј-CAG AC T GCC TTG GGA AAA GC -3Ј) to amplif y a 1.2 kb fragment. T wo independent clones (2N-16 and 2N-26) were verified for the homologous recombination ( Fig. 1 B, C) . The 2N-26 clone contributed to chimeric males that transmitted the targeted allele to the germ line. A mutant mouse line was established in a mixed background between 129/SvJ and C57BL /6.
Genot yping. The genotyping protocol for the M 3 allele was described previously (Matsui et al., 2000) . The procedure for the M 2 allele was similar, except that the primers used were M F26 (5Ј-GGT TGG GTG CAT TGG TTA GT-3Ј), PR1 (5Ј-CAG AC T GCC TTG GGA AAA GC -3Ј), and MR22 (5Ј-GTG TTC AGT AGT CAA GTG GC -3Ј).
Northern anal ysis. An M 2 probe was prepared from a 510 bp genomic DNA fragment (SmaI-SmaI) corresponding to the mouse M 2 -encoding region (129/SvJ origin). For M 4 and the glyceraldehyde-3-phosphate dehydrogenase gene (Gapd) probes, DNA fragments were amplified by PCR from cloned genomic DNA fragments of a 129/SvJ mouse and from a genomic DNA of a C57BL /6 mouse, respectively. The primers used were as follows: for M 4 , M4F (5Ј-AGC CGC AGC CGT GTT CAC AA-3Ј) and M4R (5Ј-TGG GTT GAG GGT TCG TGG C T-3Ј); and for Gapd, GapdF (5Ј-GCG TCC TGC ACC AAC TG-3Ј) and GapdR (5Ј-ATG GTC C TT TAC TCG AAG TG-3Ј).
Generation of M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice. The mouse colony was maintained in a specific pathogen-free area, and the lights in the animal room were turned on between 7:00 A.M. and 7:00 P.M. The M 2 Ϫ/Ϫ mice (N3 generation) and M 3 Ϫ/Ϫ mice (N2 generation) were crossed to obtain the M 2 ϩ/ϪM 3 ϩ/Ϫ mice. Intercross between these mice yielded pups of various genotypes for M 2 and M 3 alleles, including M 2 Ϫ/ϪM 3 Ϫ/Ϫ mutants. The descendants of these mutant mice were used for phenotypic analysis in this study. To improve the growth of the pups lacking M 3 , hydrated paste food was fed as described previously (Matsui et al., 2000) .
Blood chemistr y. Blood samples were taken intracardially from anesthetized animals and analyzed with a Fuji Dri-Chem system (model 5500) at Fujimoto Biomedical Laboratories (Osaka, Japan).
Histolog ical anal yses. All organs were fixed in 10% Formalin, embedded in paraffin, and sectioned at 4 m. Sections were stained with hematoxylin and eosin and examined under a light microscope.
In vitro responsiveness of ileal and urinar y bladder smooth muscles. The urinary bladder was prepared free of serosal connective tissue and cut into four longitudinal unfolded sections. The ileum was removed, and longitudinal muscles were isolated from the segments of the ileum (5 mm long). The preparations were placed in 5 ml organ baths containing modified Krebs-Henseleit solution maintained at 32°C, aerated continuously with 95% O 2 and 5% C O 2 , and connected to isometric transducers with sutures.
Mechanical responses were recorded isometrically by a multichannel polygraph. The tissue was equilibrated for at least 60 min with initial tension of 0.5 gm, and then contractions were induced by adding 50 mM KC l twice. The second contractile response to KC l was taken as a reference. The concentration -contraction curves for carbachol were obtained by cumulative addition of carbachol to the organ bath.
Trains of EFS (pulses at 1 or 10 Hz) were given for 10 sec at 5 min intervals. Each pulse was 45 V, 0.5 msec (bladder) or 40 V, 1 msec (ileum). After the muscle strips were contracted by 50 mM KC l for a reference, EFS was applied to cause basal contraction. To obtain noncholinergic contraction of wild-type muscle, atropine (10 M) was applied subsequently.
RESULTS
Generation of M 2 ؊/؊M 3 ؊/؊ mice
To establish a mouse line lacking both M 2 and M 3 receptors, we first constructed a mutant mouse line deficient in M 2 (M 2 Ϫ/Ϫ mice) (Fig. 1 ). The M 2 Ϫ/Ϫ mice seemed healthy, consistent with another report on a similar mutant line lacking M 2 (Gomeza et al., 1999a) . We crossed our M 2 Ϫ/Ϫ mice with the M 3 Ϫ/Ϫ mice (Matsui et al., 2000) to produce M 2 ϩ/ϪM 3 ϩ/Ϫ mutants and further intercrossed these M 2 ϩ/ϪM 3 ϩ/Ϫ mice to obtain M 2 Ϫ/ϪM 3 Ϫ/Ϫ mutants. Among the pups, the M 2 Ϫ/ϪM 3 Ϫ/Ϫ mutants were found at the Mendelian ratio (data not shown), excluding lethality in utero.
Although cholinergic signals are involved in the control of vital organs, such as gastrointestinal (Goyal and Hirano, 1996; Furness, 2000) and urinary (Andersson, 1998) tracts, the M 2 Ϫ/Ϫ M 3 Ϫ/Ϫ pups survived to adulthood after a transient postweaning growth retardation (data not shown). The growth of M 2 Ϫ/Ϫ M 3 Ϫ/Ϫ pups was improved by feeding paste food, reflecting their impaired salivation as a result of the loss of M 3 -mediated signals (Matsui et al., 2000) . The M 3 Ϫ/Ϫ mice of either sex were fertile (Matsui et al., 2000) , despite the proposed roles of the muscarinic receptor in genital organs (Lepor and Kuhar, 1984; Eglen et al., 1989) . Because M 2 and M 3 receptors are coexpressed in the uterus (Choppin et al., 1999) and prostate (Pontari et al., 1998) , it was conceivable that M 2 receptors compensated for the lost function of M 3 . However, the M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice of either sex were still fertile. Together, the M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice were unexpectedly healthy, despite the proposed importance of these receptors in the functions of various autonomic organs. 
Sex difference in urinary retention phenotype
In the urinary bladder, muscarinic contraction of the detrusor muscle is considered to be the main source of voiding power (Andersson, 1998) , and muscarinic antagonists have been applied for the treatment of bladder hyperactivity in humans (de Groat and Yoshimura, 2001 ). In our previous report (Matsui et al., 2000) , the cholinergic contractility of the M 3 Ϫ/Ϫ detrusor muscle corresponded to only 5% of that of the wild-type muscle. Although there was no sex difference in the degree of such in vitro deficits, urinary disturbance was severe in males but only mild in females, suggesting that the contribution of M 2 is significantly larger in females. However, the urinary bladder of the M 2 Ϫ/Ϫ mice seemed normal in both sexes. Furthermore, the bladder diameter of the female M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice (5.9 Ϯ 0.7 mm; n ϭ 4) was not significantly different ( p ϭ 0.81) from that of the female M 3 Ϫ/Ϫ mice (5.7 Ϯ 0.5 mm; n ϭ 7) reported by Matsui et al. (2000) . Consistent with a minor urinary retention phenotype, the kidney histology was normal (data not shown). In males, the bladder distension in the M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice (14.5 Ϯ 1.4 mm; n ϭ 4) was not significantly different ( p ϭ 0.29) from that in the M 3 Ϫ/Ϫ mice (12.3 Ϯ 1.3 mm; n ϭ 6) reported by Matsui et al. (2000) . Urinalysis and blood chemistry data for renal functions were normal in both sexes (data not shown). Thus, M 3 , but not M 2 , is essential for voiding in males, but the contribution by M 2 or M 3 in female urination is rather small. Although the reason for the sex difference is unclear, it is conceivable that the roles of the central muscarinic receptors in urination (Ishiura et al., 2001) are different between the sexes. An alternative and more plausible explanation is that there is an additional, nonmuscarinic postjunctional mechanism in females that mediates urination in the M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice (see Discussion).
Normal appearance of digestive tracts
In the digestive tract, both M 2 and M 3 mediate the intestinal smooth muscle contraction (Ehlert et al., 1999; Eglen, 2001) , which is considered the basis of functional gut movements, including peristalsis (Goyal and Hirano, 1996; Furness, 2000) . Loss of peristalsis should be fatal, as exemplified by a clinical condition called acute colonic pseudo-obstruction, in which cholinergic dysfunction is implicated (Ponec et al., 1999) . Therefore, we anticipated severe malfunctions in the gut of the M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice. Unexpectedly, they showed no signs of abnormal abdominal distension or constipation. At necropsy, the whole digestive tract of the M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice seemed normal (data not shown). Histological examinations revealed no abnormalities in the gastric, jejunal, or ileal sections (Fig. 2) . Other visceral organs, such as the heart, lung, and spleen, appeared normal at gross and histological examinations (data not shown). Muscarinic receptors are implicated in gall bladder contraction (Parkman et al., 1999a) and in pancreatic endocrine (Boschero et al., 1995) and exocrine (Schmid et al., 1998) secretions. However, blood biochemistry data were normal, including those representing the hepatic and pancreatic functions (data not shown).
In vitro contractility of smooth muscles to carbachol
Although M 2 and M 3 receptors have been implicated in cholinergic contraction (Sawyer and Ehlert, 1998; Matsui et al., 2000; Stengel et al., 2000; Giglio et al., 2001) , the mice lacking both receptors showed no apparent abnormalities in the autonomic organs, except for the urinary retention in males. Because pharmacological analyses in these reports were inconclusive, it was conceivable that cholinergic signaling remained intact through other muscarinic receptor subtypes. To address this issue, we examined in vitro contractility of the detrusor muscle (Fig. 3 A, B) and of the ileal longitudinal smooth muscle (Fig. 3C,D) . Their contractility in response to 50 mM KCl was comparable among wild-type, M 2 Ϫ/Ϫ, M 3 Ϫ/Ϫ, and M 2 Ϫ/ϪM 3 Ϫ/Ϫ tissues. Strikingly, however, the M 2 Ϫ/ϪM 3 Ϫ/Ϫ muscles did not respond to carbachol, even at concentrations (e.g., 10
Ϫ5 M) that evoked maximal contractions in the wild-type muscles. Although application of higher dosages induced small contractions, these responses were blocked by hexamethonium, which indicated a slight contribution by nicotinic receptors (data not shown). Regarding the role of each subtype in mediating contractions, the proportions reduced by the M 3 loss (95% in the bladder, 72-77% in the ileum) reported by Matsui et al. (2000) were essentially the same as those that remained in the M 2 Ϫ/Ϫ tissues (Fig. 3) (Stengel et al., 2000) . Thus, we conclude that M 2 and M 3 receptors are entirely responsible for the cholinergic contraction of smooth muscles in an additive manner.
In vitro contractility of smooth muscles to EFS
When stimulated in an electrical field, intramural neurons of the smooth muscle tissue release multiple endogenous neurotransmitters that elicit muscle contractions. To estimate the possible difference in the noncholinergic component of the EFS-induced contraction, we compared the responses between the mutant tissues with those of the wild type treated with atropine.
When the male bladder strips were stimulated in an electrical field at 10 Hz frequency, the noncholinergic (i.e., atropineresistant) contraction was significantly weaker in the mutants than in the wild type (40.3 vs 102.3%; p Ͻ 0.05) (Fig. 4 B) . A similar tendency was detected in the stimulation at 1 Hz frequency (8.9 vs 18.2%; p ϭ 0.065) (Fig. 4 A) . This reduction may reflect a functional damage to the intramural noncholinergic neurons, which may be caused by the severe extension of the bladder wall. In the female mutant tissue, in contrast, noncholinergic components were substantially larger (24.3 vs 12.9% at 1 Hz and 115.6 vs 84.3% at 10 Hz; statistically not significant) (Fig. 4 A, B) . This may reflect a weak compensatory upregulation of the noncholinergic contraction mechanism.
In the ileum of females, the noncholinergic response elicited by EFS at 10 Hz frequency was stronger in the mutants than in the wild type (65.6 vs 25.2%; p Ͻ 0.01) (Fig. 4 D) . A similar tendency was detected in males as well when stimulated at 1 Hz (16.7 vs 7.3%; p ϭ 0.23) (Fig. 4C) . These findings may suggest that the noncholinergic excitatory stimulations were upregulated in a compensatory manner.
Finally, we analyzed the sex difference in the proportion of cholinergic contraction to the total contraction in the wild-type tissues. Interestingly, cholinergic components in the urinary bladder contraction were larger in males than in females. In males, the contributions of cholinergic contraction were 28% (1 Hz stimulation) to 45% (10 Hz stimulation), whereas they were only 18% (1 Hz stimulation) to 27% (10 Hz stimulation) in females. This is consistent with our interpretation of the sex difference in the urinary retention phenotype that the cholinergic mechanism in vivo is more important in males than in females.
Pupillary constriction by M 2 loss
Muscarinic stimulation is known to cause strong constriction of the pupil (Gil et al., 2001) . As reported previously (Matsui et al., 2000) , the M 3 Ϫ/Ϫ mice showed partially dilated pupils (Fig. 5C ). In contrast, the pupil size of the M 2 Ϫ/Ϫ mice looked normal (Fig.  5B) , suggesting that M 2 is dispensable for normal pupillary function. Strikingly, however, the M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice had smaller pupils (Fig. 5D ) than the M 3 Ϫ/Ϫ mice (Fig. 5C) . These results suggest a role of M 2 in dilation, rather than constriction, of pupils. An instillation of 1% atropine solution resulted in additional mydriasis (Fig. 5E ), suggesting that M 1 , M 4 , and/or M 5 receptors might play some additional roles in constricting the pupils in the M 2 Ϫ/ϪM 3 Ϫ/Ϫ mouse (see Discussion).
DISCUSSION
Role of muscarinic receptor subtypes in cholinergic contractions
Whereas M 3 is known to play a dominant role in eliciting smooth muscle contractions, the significance of other colocalizing subtypes has been understood poorly. Thus far, the following indirect roles of M 2 have been suggested. (1) Relaxation of smooth muscles induced by isoproterenol could be reversed by the stimulation of M 2 through the inhibition of adenylate cyclase (Ehlert et al., 1999) . (2) Stimulation of M 2 may have a modulatory role on the intracellular signaling of M 3 (Ehlert et al., 1999) . Here, we demonstrated that M 2 has considerable potency to contract the muscle "directly," i.e., independent of the coexisting M 3 receptors or accompanying stimuli to increase cAMP levels. From the response curves shown in Figure 3 , we estimated the proportion of contribution by each subtype. Contributions by M 1 , M 2 , M 3 , M 4 , and M 5 receptors were ϳ0, 5, 95, 0, and 0%, respectively, in detrusor muscle contraction and ϳ0, 25, 75, 0, and 0%, respectively, in ileal longitudinal muscle contraction. The mechanism of the direct contraction through M 2 remains unclear, but it may involve the opening of nonselective cation channels (Kotlikoff et al., 1999) .
In vivo significance of cholinergic contractions in visceral organs
In humans, systemic administration of atropine delays gastric emptying (Parkman et al., 1999b) and reduces colonic motility (O'Brien et al., 1997) . Therefore, muscarinic antagonists, such as atropine, are used widely as a premedication to reduce gastrointestinal movements. However, an elaborate study (Waxman et al., 1991) showed the clinical efficacy of such anticholinergic pretreatment in colonoscopy to be limited, raising a question about the role of cholinergic signaling in smooth muscle contraction in vivo.
Loss of key molecules in gastrointestinal motility can lead to the apparent bowel obstruction in the relevant mutant mice, as exemplified by enlarged stomachs of the mice deficient in neuronal nitric oxide synthase (Huang et al., 1993) . However, we found no such obstruction phenotype in the gastrointestinal or female urinary tracts, despite the complete loss of cholinergic contractions in these tissues. Thus, cholinergic contractions cannot be regarded as a prerequisite for the basal function of these organs. It is worth noting that the phenotypes are essentially identical between our gene-targeted mice and the in vivo effects caused by an acute pharmacological block of the muscarinic receptors (Hardman et al., 2001) . Low doses of atropine cause dryness of the mouth, and moderate doses result in mydriasis. We reported a similar phenotype in the M 3 Ϫ/Ϫ mice (Matsui et al., 2000) . The urinary disturbance and inhibition of peristalsis become evident at relatively high dosages. Consistent with the intact gut appearance of M 2 Ϫ/ϪM 3 Ϫ/Ϫ mutant mice, it was reported that acute administration of a high dose of atropine did not block gut motility completely (Ruwart et al., 1979; Calignano et al., 1992) .
In the intestines and female bladder, neurotransmitters other than ACh should contribute significantly to the smooth muscle contractions in vivo and compensate for the loss of cholinergic signaling sufficiently. In fact, neurotransmission in the enteric nervous system is characterized by functional redundancy through multiple parallel pathways (Goyal et al., 1996; Furness, 2000) . In our EFS experiment, a substantial increase in noncholinergic (i.e., atropine-resistant) contraction was detected in the female M 2 Ϫ/ϪM 3 Ϫ/Ϫ tissues. These results suggest that excitatory inputs other than the cholinergic stimuli were upregulated in the mutant tissue and contributed to the functional compensation in vivo under certain conditions. In the intestines, such inputs may be mediated by tachykinins (Holzer and Holzer-Petsche, 1997) or novel neurotransmitters yet to be identified. In female urination, other parasympathetic neurotransmitters, such as purine (Burnstock et al., 1972) , should be of primary importance, because neurotransmission blockade at the parasympathetic ganglion results in severe urinary retention (Xu et al., 1999a,b) .
M 2 as a pupil dilator
We found that the pupils of the M 2 Ϫ/ϪM 3 Ϫ/Ϫ mice are unexpectedly smaller than those of the M 3 Ϫ/Ϫ mice. It is worth noting that muscarinic autoreceptors inhibiting ACh release were found in the parasympathetic nerve terminals in the iris, and the subtype was presumed to be M 2 (Bognar et al., 1990) . Lack of such autoreceptors would result in ACh over-release. Because topical applications of atropine caused full mydriasis in the M 3 Ϫ/Ϫ (Matsui et al., 2000) and M 2 Ϫ/ϪM 3 Ϫ/Ϫ (Fig. 5E ) pupils, it is conceivable that the over-released ACh stimulated the residual subtypes (M 1 , M 4 , and/or M 5 ) and caused the relative mydriasis.
However, precise mechanisms of the phenomenon remain inconclusive, because atropine interferes with other receptors, such as histamine receptor H 1 at high concentrations in the range of 1-10 M (Arunlakshana and Schild, 1959) . Because the actual concentration at the smooth muscle of the iris cannot be determined, it is uncertain whether the effects of atropine are selective only to the muscarinic receptors (1% solution is ϳ0.03 M).
It should be noted that small amounts of M 2 are expressed in other tissues of the iris, such as the pupillary sphincter muscle (Ishizaka et al., 1998) and the sympathetic nerve terminals at the dilator muscle (Jumblatt and Hackmiller, 1994) . However, our results are unlikely to be caused by the effects in such tissues. It is also possible that loss of M 2 altered cholinergic neurotransmission in the CNS and influenced the reflex control of the pupil. In fact, a tonic muscarinic inhibitory input to the Edinger-Westphal nucleus was found in the dog (Sharpe and Pickworth, 1981) .
Finally, it may be speculated that other subtypes, particularly M 1 and M 5 , were upregulated as a result of M 2 loss and contributed to the relative miotic phenotype of the M 2 Ϫ/ϪM 3 Ϫ/Ϫ animals. However, this seems rather unlikely, because no compensatory changes in other subtypes have been found in any previous reports on muscarinic receptor-deficient mice (Hamilton et al., 1997; Gomeza et al., 1999a,b; Matsui et al., 2000; Yamada et al., 2001a,b) .
Conclusion
We discovered that cholinergic contractions are not necessarily required for gastrointestinal or female urinary functions. These pieces of information should facilitate additional studies on other mediators and help establish a valid rationale for developing better drugs for diseases with autonomic dysregulation. Such diseases include urinary incontinence, irritable bowel syndrome, and posttraumatic stress disorder. Thus far, M 2 receptors are considered to play only minor roles in smooth muscles, despite its abundant expression. Our gene-targeted mice should be useful to further unravel the functions of this subtype. In fact, we demonstrated an unexpected role of M 2 in pupillary dilation that may help develop a novel class of muscarinic drugs for ocular diseases.
